Furthermore, the fraction of recruited as well as tumor-resident proliferating (Ki67+) CD8+T cells was higher in tumor fields compared with tumor stroma (7% vs 3%, p=0.015 and 14% vs 7%, p=0.002, respectively, online supplemental figure 2B, C). This evidence concerns the gene MKI67 and neoplasm.